Antithrombotic therapy in atrial fibrillation.
Albers
G W
GW
Stanford Stroke Center, Palo Alto, CA 94304-1705, USA. albers@leland.stanford.edu
Dalen
J E
JE
Laupacis
A
A
Manning
W J
WJ
Petersen
P
P
Singer
D E
DE
D000284:Administration, Oral; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D004554:Electric Countershock; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D020521:Stroke / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin